Skip to main content

Table 5 Hemodynamics and cardiac physiology parameters

From: The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats

Parameter

Group

Control

Empagliflozin

Systolic BP [mmHg]

115 ± 17

126 ± 14

Diastolic BP [mmHg]

78 ± 13

91 ± 11

HR [bpm]

454 ± 76

374 ± 68

SV [µl]

98 ± 12

112 ± 23

CO [m/min]

19.7 ± 3.1

22.3 ± 3.8

EF [%]

23.2 ± 2.7

25.8 ± 6.2

SW [mmHg*µl]

6680 ± 2208

7175 ± 2822

dp/dt max [mmHg/sec]

5252 ± 2011

5453 ± 441

dp/dt min [mmHg/sec]

− 3324 ± 1547

− 3417 ± 771

  1. BP blood pressure, HR Heart rate, SV stroke volume, CO cardiac output, EF ejection fraction, SW stroke work, dp/dt max and min rate of pressure change at systole and diastole, respectively